Medically reviewed by Dr. Tom Biernacki, DPM
Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Township, MI
Last reviewed: May 2026

| Oral Antifungal | Standard Dose | Duration | Mycological Cure Rate | Complete Cure Rate | Main Risks |
|---|---|---|---|---|---|
| Terbinafine (Lamisil) | 250 mg daily | 12 weeks (toenails) | 70–80% | 35–50% | GI upset, rare hepatotoxicity, dysgeusia |
| Itraconazole — continuous | 200 mg daily | 12 weeks | 55–70% | 25–40% | QT prolongation, negative inotropy, drug interactions |
| Itraconazole — pulse | 200 mg BID × 1 wk/month | 3–4 pulse cycles | 55–65% | 25–35% | Same as above; lower total dose |
| Fluconazole | 150–300 mg/week | 6–12 months | 45–55% | 20–30% | Drug interactions, hepatotoxicity (less than itraconazole) |
| Griseofulvin (older agent) | 500–1000 mg daily | 12–18 months | 30–40% | ~15% | Photosensitivity, GI, teratogenic — rarely used now |
| Clinical Factor | Preferred Choice | Rationale |
|---|---|---|
| Standard healthy adult, dermatophyte | Terbinafine 250 mg × 12 wks | Highest cure rate, shortest duration |
| Terbinafine intolerance or allergy | Itraconazole pulse × 3 cycles | Effective alternative, less CYP interaction than fluconazole |
| Non-dermatophyte mold (Aspergillus, Fusarium) | Itraconazole or voriconazole | Terbinafine less active against molds |
| Candida onychomycosis | Fluconazole or itraconazole | Better activity against Candida species |
| Cardiac disease (CHF, arrhythmia) | Terbinafine (avoid itraconazole) | Itraconazole has negative inotropy; contraindicated in CHF |
| Liver disease / heavy alcohol use | Caution with all — consider topical only | All oral agents carry hepatotoxicity risk; weigh benefit/risk |
| Elderly (>75) with polypharmacy | Check drug interactions carefully | Both itraconazole and fluconazole are CYP3A4 inhibitors |
Quick answer: Treatment for onychomycosis oral treatment follows a stepwise approach: 1) conservative care first (rest, ice, supportive footwear, OTC anti-inflammatories), 2) physical therapy and targeted exercises, 3) in-office treatments (injections, custom orthotics) if conservative fails at 4-6 weeks, 4) surgery for refractory cases. Most patients resolve at step 1 or 2. Call (810) 206-1402.
Medically Reviewed | Dr. Tom Biernacki, DPM | Board-Certified Podiatrist | Balance Foot & Ankle, Michigan | 5,000+ patients/year
Why Oral Antifungals Work Better Than Topicals
Fungal nail infections involve the nail matrix and nail bed beneath the nail plate. Topical antifungals penetrate poorly through thick nail plate to reach the fungal source. Oral antifungals are delivered systemically to the nail bed through the bloodstream — reaching the actual location of fungal growth. This is why oral treatment achieves 70–80% cure vs. 5–15% for standard topicals (efinaconazole topical achieves 15–18% in trials).
Terbinafine: First-Line Treatment
Dose: 250mg once daily for 12 weeks (toenails) or 6 weeks (fingernails). Mechanism: Fungicidal — kills the fungus by inhibiting ergosterol synthesis. Efficacy: 70–80% mycological cure; 35–50% complete cure (clear nail). Drug interactions: CYP2D6 interactions — check with a pharmacist. Liver monitoring: Baseline LFT; repeat at 6 weeks for patients with risk factors. Hepatotoxicity is rare (1 in 50,000–120,000) but monitoring is prudent.
Itraconazole: Second-Line Option
Pulse dosing: 200mg twice daily for 1 week per month x 3 months. Efficacy slightly lower than terbinafine. More drug interactions (CYP3A4 inhibitor). Negative inotrope — contraindicated in heart failure. Useful for dermatophyte nail infections when terbinafine is contraindicated or failed.
Setting Expectations: The Timeline
Oral antifungals work during treatment but results are only visible as the nail grows out. Toenails grow approximately 1–1.5mm per month — a big toenail takes 12–18 months to fully replace. Patients who finish 12 weeks of terbinafine and see no change at week 16 have not failed treatment — the clear nail simply hasn’t grown out yet. Final assessment at 18 months post-treatment.
FAQs
Do I need a liver function test before starting terbinafine? Recommended — particularly if you have liver disease, take other liver-metabolized medications, or consume significant alcohol. Your prescribing physician will determine if baseline LFTs are needed.
🧴 Dr. Tom’s Toenail & Nail Care Picks
For nail conditions, these are the at-home products I rely on most alongside professional treatment.
For discomfort around the nail bed. Arnica + menthol — plant-based, FSA-eligible. Apply to the area 3-4x daily. No greasy residue.
View on Amazon →
Reduces pressure on nails by improving load distribution. My #1 OTC pick for nail patients who stand or walk all day.
View on Amazon →
FTC Disclosure: As an Amazon Associate and Foundation Wellness affiliate, we earn from qualifying purchases. This never affects our clinical recommendations.
Michigan Foot & Ankle? See Dr. Biernacki In Person
Same-week appointments at our Howell and Bloomfield Township offices.
📞 (810) 206-1402 Book Online →Frequently Asked Questions
Recommended by Dr. Biernacki
Products our Michigan patients trust for foot & ankle recovery — curated by Dr. Tom.
Shop Foundation Wellness Products →In-Office Treatment at Balance Foot & Ankle
If home treatment isn’t providing relief for your toenail fungus, our podiatry team at Balance Foot & Ankle can help with same-week evaluations and advanced in-office care.
AAD: Nail Fungus (Onychomycosis)
Ready to Get Relief?
Same-week appointments available in Howell & Bloomfield Township, MI
4.9★ | 1,123 Reviews | 3,000+ Surgeries
Or call: (810) 206-1402
Dr. Tom Biernacki, DPM is a board-certified foot & ankle surgeon (ABFAS & ABPM) at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has made him one of the most-followed foot & ankle educators on YouTube.